Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026)
Palisade Bio (PALI) posted quarterly Other Working Capital Changes of $127000.0 for Q3 2025, up 496.88% year-over-year from $21277.5 in Q3 2024, and up 473.53% quarter-over-quarter from -$34000.0 in Q2 2025.
Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has reported Other Working Capital Changes for 13 consecutive years, with $127000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 496.88% year-over-year to $127000.0; the TTM figure through Mar 2026 stood at $93000.0 (up 2425.0% YoY), while the FY2025 annual figure was $61000.0, changed N/A from the prior year.
- Other Working Capital Changes rose to $127000.0 in Q3 2025 per PALI's latest filing, from -$34000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $519000.0 in Q3 2025 and bottomed at -$1.1 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$178411.8 across 5 years, with a median of -$175000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 1682.61% — and 2025, when it soared 496.88%.
- Palisade Bio's Other Working Capital Changes stood at $23000.0 in 2021, then plunged by 1682.61% to -$364000.0 in 2022, then surged by 143.41% to $158000.0 in 2023, then sank by 43.67% to $89000.0 in 2024, then jumped by 42.7% to $127000.0 in 2025.
- Business Quant data shows PALI's Other Working Capital Changes at $127000.0 in Q3 2025, -$34000.0 in Q2 2025, and -$32000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 937,000.00 |
| Jun 30, 2026 | 937,000.00 |
| Jun 30, 2026 | 937,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | 519,000.00 |
| Sep 30, 2025 | 519,000.00 |
| Sep 30, 2025 | 519,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |